TickerFacts.

Mangoceuticals, Inc. (MGRX): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$5.85M
Year ended 2025-12-31
-$3.89M
Trailing 12 months to 2026-06-30
2022-12-31: -$1.35M2023-12-31: -$7.00M2024-12-31: -$4.86M2025-12-31: -$5.85M-$5.85M
2022-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31-$5.85Mn/m2026-04-01, From 2025-01-01
2024-12-31-$4.86Mn/m2026-04-01, From 2024-01-01
2023-12-31-$7.00Mn/m2025-03-20, From 2023-01-01
2022-12-31-$1.35Mn/a2024-04-01, From 2022-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Services-Misc Health & Allied Services, NEC), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Mangoceuticals, Inc. (MGRX)2025-12-31-$5.85Mn/m
BioRestorative Therapies, Inc. (BRTX)2025-12-31-$10.79Mn/m
Charming Medical Ltd (MCTA)2026-03-31-$1.22Mn/m
Pacific Health Care Organization Inc (PFHO)2025-12-31$1.16M+71.9%
Marpai, Inc. (MRAI)2025-12-31-$7.45Mn/m
Cryo Cell International Inc (CCEL)2025-11-30$5.48M-8.9%
Viemed Healthcare, Inc. (VMD)2025-12-31$51.92M+32.8%
Sotera Health Co (SHC)2025-12-31$287.19M+28.1%
Progyny, Inc. (PGNY)2025-12-31$210.19M+17.4%

Compare MGRX, BRTX, MCTA, PFHO side by side · Screen every company in Services-Misc Health & Allied Services, NEC ↗